ArticleThe FEBS journal2026
Variability in intracellular localization of D-amino acid oxidase in choroid plexus epithelial cells.
Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
D-amino acid oxidase (DAO; also abbreviated as DAAO) in the brain is primarily expressed in glial cells of the cerebellum and brainstem. In glial cells, DAO metabolizes D-serine, which acts as a co-agonist and regulator of glutamate receptors. We previously reported that DAO is also expressed in epithelial cells of the choroid plexus (CP); however, the subcellular localization and functional significance of DAO in the CP remain unclear. In this study, we performed histological analyses to investigate the subcellular localization of DAO in the CP. We first confirmed DAO expression in the mouse CP. Immunostaining revealed vesicle-like DAO signals in the cell bodies of choroid plexus epithelial cells (CPECs). Super-resolution microscopy was then used to evaluate colocalization with intracellular organelle markers. DAO signals partially colocalized with ATP-binding cassette subfamily D member 3 (PMP70) and peroxisomal targeting signal 1 receptor (PEX5). In contrast, they colocalized with Golgin subfamily A member 2 (GM130), trans-Golgi network integral membrane protein 2 (TGN46), adaptor protein complex AP-2 (AP-2), early endosome antigen 1 (EEA1), Ras-related proteins Rab5a, Rab11, CD63 antigen (CD63), tumor susceptibility gene 101 protein (TSG101), lysosome-associated membrane glycoprotein 1 (LAMP-1), LAMP-2, beclin-1 and microtubule-associated protein 1 light chain 3 (LC3). These findings suggest that, in the CP, DAO is transported from the Golgi apparatus to endosomes and subsequently distributed to multiple vesicular compartments. The presence of DAO in peroxisomes, autophagosomes, lysosomes, and exosomes indicated diverse intracellular localization within CPECs. This distribution may enable efficient metabolism of blood-derived D-serine in CPECs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.